Progenie molecular is a biomedical company specialized in molecular diagnostics. We use the latest biotechnology to perform the following activities:
- Molecular diagnostic tests and genetic identification.
- Products for in vitro diagnostics and research
The company is organized in 2 functional units.
Progenie molecular aims to develop and implement innovative solutions for the diagnosis, prevention and monitoring of diseases.
Our desire is to help those who are affected by a disease and professionals of health in making clinical decisions, while providing technological development of our society.
To do this we rely on innovation, professionalism, quality and desire for improvement... always focused on the most important: the health of people.
Diana Corella is the technical manager. Diana is a molecular biologist with an experience of over 13 years in the company.
Diana has held various positions of responsibility within Progenie molecular. She initially dealt Molecular Diagnostics and Genetic Identification Unit. Later she held the leadership of the Production Unit of in-vitro diagnostics reagents and the responsibility of the Quality Department.
Progenie molecular has its modern facilities in an exclusive building of 600 m2, of which nearly 200 m2 are dedicated to a laboratory equipped with the latest equipment to carry out the most modern techniques of molecular diagnosis and genetic identification.
We are in the city of Valencia, close to the Hospital 9 de Octubre and the Bioparc, in an environment with numerous centers of the health sector.
Progenie molecular has two certified quality systems: ISO 9001:2008 and ISO 13485:2003, covering the following activities:
- Clinical diagnostics service in the areas of genetics, virology, serology, molecular microbiology and genetic identification.
- Design, development, production and marketing of products for in vitro diagnostics, and scientific research based on molecular biology.
All technical work is verified by biological controls provided by independent organizations such as NIBSC (National Institute for Biological Standards and Controls) QCMD (Quality Control for Molecular Diagnostics) and QNOSTICS.
The company participates in external quality exercises from different groups and organizations, such as Spanish and Portuguese Group of the International Society for Forensic Genetics (ISFG-GHEP).
Spanish Association of Human Genetics (AEGH)
European Society of Human Genetics (ESHG)
Spanish Soc. Infectious Dis. and Clin. Micro. (SEIMC)
Spanish Society of Virology (SEV)
International Soc. Forensic Genetics (ISFG)
European Soc. Clin. Micro. and Infectious Dis. (ESCMID)
Spanish Society of Molecular Diagnostics (SEDM)
Spanish Assoc. Cervical Path. and Colposcopy (AEPCC)
European Directory Diagnostic DNA Labs (EDDNAL)
Spanish Society of Virology
International Soc. Forensic Genetics
European Soc. Clin. Micro. and Infectious Dis.
Spanish Association of Familial Spastic Paraparesis
Progenie molecular is a company licensed by the Spanish Agency of Medicines and Health Products (AEMPS) for the production of in vitro diagnostic reagents.
Our products comply with European Directive 98/79/EC about in vitro diagnostic, and the Royal Decrees 1662/2000 and 1591/2009 regulating the manufacture of medical devices in Spain.
Progenie molecular is a lab accredited for molecular diagnosis of genetic and infectious diseases (registration No. 5568-GV).
This authorization is required to process clinical samples and the issuance of a clinical report with the result.
As a registered laboratory, our facilities are subject to regulatory requirements and regular inspections carried out by health administrations.
Progenie molecular complies with all legal requirements regarding data protection, prevention of occupational hazards and toxic waste management.